Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » IntelligentMDx

IntelligentMDx

Nov 14, 2013

Dx Focus: FDA OKs IntelligentMDx C. Difficile Abbott m2000 Assay

Premium

IntelligentMDx said today that it has received US Food and Drug Administration clearance for its IMDx C.

Nov 12, 2013

FDA Clears IMDx C. Difficile Assay for Abbott m2000 System

NEW YORK (GenomeWeb News) – IntelligentMDx today said that the US Food and Drug Administration has cleared its C. difficile assay for the Abbott m2000 system.

Sep 12, 2013

Dx Focus: IMDx Flu and RSV Tests Get FDA Clearance

Premium

IntelligentMDx said this week that the US Food and Drug Administration has cleared the company's automated molecular diagnostic test for influenza A, influenza B, and respiratory syncytial virus for use on the Abbott m2000 platform.

Sep 10, 2013

FDA Clears IMDx Test for Flu, Respiratory Virus

NEW YORK (GenomeWeb News) – Molecular diagnostic firm IntelligentMDx today announced its flu and respiratory virus test has been cleared by the US Food and Drug Administration for marketing in the US.

Aug 01, 2013

Dx Focus: BioFire Diagnostics, IntelligentMDx, Cepheid, Enigma Diagnostics

Premium

BioFire Diagnostics said this week that it has commenced clinical and analytical studies to evaluate its FilmArray Gastrointestinal Panel with plans to seek both CE IVD marking and US Food and Drug Administration clearance.

Jul 29, 2013

FDA Clears IMDx's MDx for Vancomycin-resistant Enterococci

NEW YORK (GenomeWeb News) – IntelligentMDx today announced it has received clearance from the US Food and Drug Administration for its molecular diagnostic test for vancomycin-resistant enterococci.

Jan 10, 2013

Qiagen Looks to IMDx to Accelerate Test Menu Development for QiaSymphony RGQ Platform

Premium

IntelligentMDx said this week that it has entered into a multi-year development and licensing agreement with Qiagen to design, develop, and manufacture several undisclosed assays for use on Qiagen's QiaSymphony RGQ automated molecular testing platform.

Jan 07, 2013

IntelligentMDx Developing Assays for Qiagen's QIAsymphony RGQ

NEW YORK (GenomeWeb News) – IntelligentMDx said today that it has entered into a development and licensing agreement to design, develop, and manufacture CE-marked and US Food and Drug Administration-cleared diagnostic tests for use on Qiagen's QIAsymphony RGQ platform.

Dec 20, 2012

People in the News: Maurice Exner Joins IMDx as VP of R&D

Premium

IntelligentMDx said this week that Maurice Exner has joined the company as vice president of research and development.

Jul 20, 2012

In Brief This Week: IntelligentMDx; Techne; Qiagen; Horizon Discovery; Penn Genome Frontiers Institute

NEW YORK (GenomeWeb News) – IntelligentMDx has received the CE Mark for its herpes simplex virus molecular test.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.